Construction Machinery and Heavy Transportation Equipment

Blue Bird

Blue Bird released FY2026 Q2 earnings on May 6 After-Market EST, actual revenue USD 352.64 M (forecast USD 336.63 M), actual EPS USD 0.9 (forecast USD 0.8683)

Blue Bird Corporation Reports Q2 2026 Earnings and Raises Full Year Guidance

Blue Bird released FY2026 Semi-Annual earnings on May 6 After-Market EST, actual revenue USD 685.72 M, actual EPS USD 1.8399

Blue Bird to Release FY2026 Q2 Earnings on May 6 After-Market EST, Forecast Revenue USD 336.63 M, EPS USD 0.8683

Blue Bird released FY2026 Q1 earnings on February 4 After-Market EST, actual revenue USD 333.08 M (forecast USD 325.74 M), actual EPS USD 0.94 (forecast USD 0.7816)

Blue Bird to Release FY2026 Q1 Earnings on February 4 After-Market EST, Forecast Revenue USD 325.74 M, EPS USD 0.7816

Blue Bird Director Buys Company Stock

Blue Bird released FY2025 Annual Earnings on November 24 After-Market EST, actual revenue USD 1.48 B (forecast USD 1.451 B), actual EPS USD 3.88 (forecast USD 3.8316)

Blue Bird released FY2025 Q4 earnings on November 24 After-Market EST, forecast revenue USD 380.37 M, forecast EPS USD 1.054

Bluebird Reports Strong Q4 and FY2025 Financial Results and Outlines FY2026 Outlook

Blue Bird to Release FY2025 Q4 Earnings on November 24 After-Market EST, Forecast Revenue USD 380.37 M, EPS USD 1.054

BTIG Raises Blue Bird Target Price to $65, Sees Strong Growth Prospects

Micro Bird USA LLC Opens New Bus Manufacturing Facility

Blue Bird released FY2025 Q3 earnings on August 6 After-Market (EST), actual revenue USD 398.01 M (forecast USD 377.64 M), actual EPS USD 1.1199 (forecast USD 0.932)

Blue Bird released FY2025 9 Months Earnings on August 6 After-Market EST, actual revenue USD 1.071 B, actual EPS USD 2.7699

Federated Hermes Reduces Stake in Blue Bird

Blue Bird to Release FY2025 Q3 Earnings on August 6 After-Market EST, Forecast Revenue USD 377.64 M, EPS USD 0.932

Asset Management One Reduces Holdings in Bluebird

Phil Horlock Reports Blue Bird Corporation Stock Disposition

Blue Bird Corporation Director Disposes of Common Stock

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

BLBD

WRBY

FRMI

CHWY

HSAI

DXYZ

FLNC

POET

MMYT

Blue Bird(BLBD) fell 11.12%, with a trading turnover 56.1 Million USD, and a year-to-date rose 37.6%. Warby Parker(WRBY) fell 10.96%, with a trading turnover 311.3 Million USD, and a year-to-date rose 17.1%. Fermi(FRMI) fell 10.38%, with a trading turnover 115.6 Million USD, and a year-to-date fell 26.6%.

Top Gainers&Losers

Warby Parker

Fermi

Uranium Energy

Chewy

Hesai

Destiny Tech100

Fluence Energy

POET Tech

MakeMyTrip

Top 10 US Stock Losers (5.19)

Blue Bird Corporation (NASDAQ:BLBD) shares fell 8.5% to $66.54, with trading volume down 93% from average levels. Analysts have mixed ratings, with price targets ranging from $55 to $86. The company reported $1.00 EPS, exceeding estimates, but revenue declined 1.7% year-over-year. Insider sales were noted, and institutional investors have increased their holdings significantly.

Market Beat

Barclays

CRISPR Therap

NVIDIA

NVIDIA Corporation

Blue Bird (NASDAQ:BLBD)  Shares Down 8.5%   - Should You Sell?

Vanguard Group Inc. increased its stake in Blue Bird Corporation (NASDAQ:BLBD) by 7.1% in Q4, owning 2,041,085 shares valued at approximately $95.93 million. Other hedge funds also raised their positions significantly. Blue Bird's stock opened at $71.00, with a market cap of $2.25 billion and a PE ratio of 17.44. The company reported a quarterly EPS of $1.00, exceeding estimates, despite a 1.7% revenue decline year-over-year. Recent insider sales were noted, and analyst ratings have varied, with some downgrades and target price adjustments.

Blue Bird Corporation $BLBD Shares Acquired by Vanguard Group Inc.

Zacks Research downgraded Blue Bird (NASDAQ:BLBD) from a "hold" to a "strong sell" rating. Other analysts have also adjusted their ratings, with Wall Street Zen downgrading it to "buy" and Needham & Company raising the price target to $86. Blue Bird's stock has a consensus rating of "Moderate Buy" and a target price of $75.80. The stock opened at $69.33, with a market cap of $2.19 billion. Recent insider sales were reported, and hedge funds have increased their positions in the company.

Blue Bird (NASDAQ:BLBD) Cut to "Strong Sell" at Zacks Research

NNBR

XMTR

AAON

HVAC

In Thursday's pre-market session, Fluence Energy (FLNC) shares surged 35.5% to $18.38 following its Q2 earnings report. AAON (AAON) rose 27.27% to $125.11 after releasing Q1 earnings. Other gainers included NN (NNBR) up 18.25%, Blue Bird (BLBD) up 17.69%, and Xometry (XMTR) up 15.24%. Conversely, Construction Group (ONEG) plummeted 74.8% to $1.65, while Stem (STEM) fell 16.83%. American Rebel Holdings (AREB) and DevvStream (DEVS) also saw significant declines. Tutor Perini (TPC) and Hudson Technologies (HDSN) dropped after their Q1 earnings announcements.

benzinga_article

Xometry

Aaon

iShares US Industrials

ISHRS S&P Glb Indus

AdvisorShares HVAC and Industrials ETF

VG Industr

Spdr Select Indu

Swvl

OneConstruction

Stem

American Rebel

DevvStream

Tutor Perini

Hudson Tech

SWVL HOLDINGS CORP C/WTS (TO PUR COM)

AMERICAN REBEL HOLDINGS INC C/WTS 20/01/2027 (TO PUR COM)

DEVVSTREAM CORP

12 Industrials Stocks Moving In Thursday's Pre-Market Session

MOTO

CARZ

CARU

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

nasdaq

SmartETFs Smart Transportation & Tech ETF

First Trust S-Network Future Vehicles & Tech ETF

Max Auto Industry 3X Leveraged ETN

Nasdaq

Blue Bird (BLBD) Q2 2026 Earnings Transcript

Blue Bird Corporation (BLBD) reported Q2 2026 results with net sales of $352.6 million, a 1.7% decline year-on-year, but GAAP net income rose to $29.3 million. Adjusted EBITDA reached a record $50.8 million, with 2,148 buses sold. The company raised its full-year guidance to $1.75 billion in net revenue and $245 million in adjusted EBITDA. Blue Bird's backlog includes over 900 electric buses, and management highlighted improved profitability despite lower unit volumes. Analysts rate BLBD stock as a Buy with a $55.00 price target, reflecting strong financial performance and growth potential.

Tip Ranks

Blue Bird Boosts Outlook After Strong Q2 2026 Results

CVS Health shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY26 guidance.

CVS Health

Blue Bird(BLBD.US)